Search

everythinglearnresearchcommunity

for

Search:↓

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

Forsythiaside A helps reduce brain damage from lack of blood flow by activating certain protective pathways.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

COVID-19 can cause skin problems in children.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Genetic mutations that disrupt homocysteine breakdown lead to increased damage in mouse hair keratin.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Systemic lupus erythematosus treatment can restore vision in patients with retinal artery occlusion.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Systemic lupus erythematosus caused severe abdominal issues in a Sudanese woman.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.